1154 related articles for article (PubMed ID: 30283077)
1. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
Lee H; Ahn J; Shin SS; Yoon M
Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
[TBL] [Abstract][Full Text] [Related]
2. The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.
Lim J; Lee H; Ahn J; Kim J; Jang J; Park Y; Jeong B; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2018 Oct; 225():31-41. PubMed ID: 29958960
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice.
Shin Y; Lee M; Lee D; Jang J; Shin SS; Yoon M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916086
[TBL] [Abstract][Full Text] [Related]
4. Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation.
Kim YJ; Choi MS; Park YB; Kim SR; Lee MK; Jung UJ
World J Gastroenterol; 2013 Aug; 19(29):4689-701. PubMed ID: 23922466
[TBL] [Abstract][Full Text] [Related]
5. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
[TBL] [Abstract][Full Text] [Related]
6. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
7. Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet.
Luo Z; Li M; Yang Q; Zhang Y; Liu F; Gong L; Han L; Wang M
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745260
[TBL] [Abstract][Full Text] [Related]
8. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
9. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
[TBL] [Abstract][Full Text] [Related]
11. Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice.
Lee D; Shin Y; Roh JS; Ahn J; Jeoong S; Shin SS; Yoon M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549364
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
13. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
[TBL] [Abstract][Full Text] [Related]
14. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
15. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
[TBL] [Abstract][Full Text] [Related]
16. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
17. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
[TBL] [Abstract][Full Text] [Related]
18. Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development.
Iñiguez M; Pérez-Matute P; Villanueva-Millán MJ; Recio-Fernández E; Roncero-Ramos I; Pérez-Clavijo M; Oteo JA
J Physiol Biochem; 2018 Nov; 74(4):635-646. PubMed ID: 30288689
[TBL] [Abstract][Full Text] [Related]
19. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
[TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
